Molecular analysis for therapy choice (MATCH) arm W: Phase II study of AZD4547 in patients with tumors with aberrations in the FGFR pathway.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Young Kwang Chae, Christos Vaklavas, Heather H. Cheng, Fangxin Hong, Lyndsay Harris, Edith P. Mitchell, James A. Zwiebel, Lisa McShane, Robert James Gray, Shuli Li, S. Percy Ivy, Sherry Singer Ansher, Stanley R. Hamilton, Paul M. Williams, James V. Tricoli, Carlos L. Arteaga, Barbara A. Conley, Peter J. O'Dwyer, Alice P. Chen, Keith Flaherty
Institutions: Northwestern University, University of Alabama at Birmingham, University of Washington, Harvard University, National Cancer Institute, Thomas Jefferson University, Sidney Kimmel Cancer Center, Dana-Farber Cancer Institute, National Institutes of Health, The University of Texas MD Anderson Cancer Center, Frederick National Laboratory for Cancer Research, Vanderbilt University, Vanderbilt-Ingram Cancer Center, Abramson Cancer Center, University of Pennsylvania, Massachusetts General Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2889959548